Skip to main content
| News

Novartis psoriasis treatment shows strong results

03.10.2016

Basel – Novartis’ Cosentyx has proven highly effective against psoriasis. The skin condition can cause psychological problems for many patients and can be very difficult to treat.

Psoriasis healing on palms. (Img: Novartis AG)

The Basel pharmacetical company Novartis has released the latest data showing that its treatment Cosentyx delivers high and long-lasting skin clearance in patients with plaque psoriasis. Over the course of a 4-year study, patients were treated with Cosentyx. 68.5 per cent of them had clear or almost clear skin after the first year, and this high rate was maintained through to the fourth year. 43.8 per cent of the patients achieved completely clear skin.

The study also looked at the long-term efficacy of Cosentyx in treating psoriasis of the hands and feet, long considered difficult areas to treat on the body. The Novartis treatment was equally effective in this regard: approximately 60 per cent of patients achieved clear or almost clear palms and soles with Cosentyx. These results continued to improve over 1.5 years.

Novartis also published the results of a global survey on psoriasis patients. It shows that 57 per cent of the 8,300 patients surveyed have not achieved clear skin with standard treatments. Many of those surveyed said that they do not believe they will ever achieve clear skin. A total of 84 per cent of those surveyed said they face discrimination and humiliation, and 38 per cent said they have been diagnosed with a psychological condition due to their psoriasis.

Novartis is keen to remedy this situation and supports the World Health Organization’s resolution to make psoriasis a global health priority. Cosentyx is already approved in many countries to treat plaque psoriasis, psoriasis arthritis and ankylosing spondylitis.

Share this article

Sign up to receive our newsletter in your inbox.

You might also be interested in

Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech, Sustainability

Evolva launches new line for manufacturers of personal care products

Evolva, a manufacturer of active ingredients based in Reinach in the canton of Basel-Landschaft, will be presenting its new product...

Read More
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Record figure for startups in the Basel Area

Basel Area Business & Innovation has supported a record number of 96 company startups in 2022. The number of settlements...

Read More
Noema Pharma raises 103 million Swiss francs from investors
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Noema Pharma raises 103 million Swiss francs from investors

Noema Pharma has raised a total of 103 million Swiss francs as part of an oversubscribed Series B financing round....

Read More
Advanced Manufacturing/AI, Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Why CDMO companies choose the Basel Area as their location

Originally, this article was published by the US magazine Outsourced Pharma under the title "Why Location Matters". The article highlights...

Read More
Basel Area Business & Innovation, Innovation, Invest

Basel still the most attractive small city for business in Europe

As with last year, Basel once again features among the most attractive locations in Europe for investments. It was ranked...

Read More
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Ariceum Therapeutics establishes subsidiary in Basel

The German life sciences firm Ariceum Therapeutics has established a subsidiary in Basel. This company has received support from Basel...

Read More
RocketVax raises fresh capital
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

RocketVax raises fresh capital

The Basel-based biotech startup RocketVax has successfully closed another financing round. This additional funding will primarily be used to further...

Read More
Clinerion is now part of Citeline
Basel Area Business & Innovation, ICT, Innovation, Invest, Life Sciences / biotech

Clinerion is now part of Citeline

Clinerion has been integrated into New York-based company Citeline. Clinerion plans to expand its portfolio with Citeline’s complementary opportunities with...

Read More
Advanced Manufacturing/AI, Basel Area Business & Innovation, Innovation, Invest, Sustainability

KUORI developing biodegradable plastics

The Basel-based cleantech company KUORI GmbH develops alternative materials for conventional plastics. The aim is to reduce the accumulation of...

Read More
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Cell and gene therapies gain momentum in Basel

Companies specializing in the research and development of innovative cell and gene therapies continue to spring up all around the...

Read More
1 2 3 37

Do you have a question? We'd like to hear from you.